This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Sandoz says it will fight new US antitrust complaint against generic manufacturers

( May 13, 2019, 15:56 GMT | Official Statement) -- MLex Summary: Sandoz Pharmaceuticals said it will fight a new price-fixing complaint filed by 43 US states and Puerto Rico. The complaint accuses 20 generic drug producers and 15 senior executives of conspiring to fix prices, allocate markets and rig bids for more than 100 generic drugs.Statement follows below: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections